Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)

6.02
Delayed Data
As of May 25
 +0.03 / +0.50%
Today’s Change
3.61
Today|||52-Week Range
12.22
-34.21%
Year-to-Date
No recent news for Galmed Pharmaceuticals Ltd.

Today’s Trading

Previous close5.99
Today’s open6.02
Day’s range6.00 - 6.05
Volume21,822
Average volume (3 months)62,261
Market cap$90.4M
Data as of 3:59pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)+34.23%
Earnings growth (this year)+25.92%
Earnings growth (next 5 years)--
Revenue growth (last year)+132.33%
P/E ratioNM
Price/Sales105.31
Price/Book5.36

Competitors

 Today’s
change
Today’s
% change
RGLSRegulus Therapeutics...+0.02+2.22%
GTXIGTX Inc+0.36+1.85%
MEIPMEI Pharma Inc-0.03-0.95%
ZFGNZafgen Inc-0.38-5.78%
Data as of 4:00pm ET, 05/25/2018

Financials

Next reporting dateJuly 31, 2018
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$1.1M
Annual profit (last year)-$12.3M
Net profit margin-1,133.55%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Allen Baharaff
Vice President-
Operations
Guy Nehemya
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts